337 related articles for article (PubMed ID: 26875618)
1. A Deadly Path: Bacterial Spread During Bubonic Plague.
Gonzalez RJ; Miller VL
Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.
Comer JE; Sturdevant DE; Carmody AB; Virtaneva K; Gardner D; Long D; Rosenke R; Porcella SF; Hinnebusch BJ
Infect Immun; 2010 Dec; 78(12):5086-98. PubMed ID: 20876291
[TBL] [Abstract][Full Text] [Related]
3. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
Lemaître N; Sebbane F; Long D; Hinnebusch BJ
Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
[TBL] [Abstract][Full Text] [Related]
4. Yersinia pestis subverts the dermal neutrophil response in a mouse model of bubonic plague.
Shannon JG; Hasenkrug AM; Dorward DW; Nair V; Carmody AB; Hinnebusch BJ
mBio; 2013 Aug; 4(5):e00170-13. PubMed ID: 23982068
[TBL] [Abstract][Full Text] [Related]
5. Antibody Opsonization Enhances Early Interactions between Yersinia pestis and Neutrophils in the Skin and Draining Lymph Node in a Mouse Model of Bubonic Plague.
Shannon JG; Hinnebusch BJ
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077628
[TBL] [Abstract][Full Text] [Related]
6. Immunogenesis in White Mice Infected with Yersinia pestis with Different Plasmid Composition.
Balakhonov SV; Vityazeva SA; Dubrovina VI; Starovoitova TP; Mukhturgin GB; Ivanova TA; Korytov KM; Kolesnikov SI
Bull Exp Biol Med; 2017 Feb; 162(4):470-473. PubMed ID: 28243913
[TBL] [Abstract][Full Text] [Related]
7. Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague.
Hinnebusch BJ; Jarrett CO; Callison JA; Gardner D; Buchanan SK; Plano GV
Infect Immun; 2011 Dec; 79(12):4984-9. PubMed ID: 21969002
[TBL] [Abstract][Full Text] [Related]
8. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague.
Sebbane F; Lemaître N; Sturdevant DE; Rebeil R; Virtaneva K; Porcella SF; Hinnebusch BJ
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11766-71. PubMed ID: 16864791
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of a highly virulent pathogen: tracking the early events that define infection.
Gonzalez RJ; Lane MC; Wagner NJ; Weening EH; Miller VL
PLoS Pathog; 2015 Jan; 11(1):e1004587. PubMed ID: 25611317
[TBL] [Abstract][Full Text] [Related]
10. Glutathionylation of
Mitchell A; Tam C; Elli D; Charlton T; Osei-Owusu P; Fazlollahi F; Faull KF; Schneewind O
mBio; 2017 May; 8(3):. PubMed ID: 28512097
[TBL] [Abstract][Full Text] [Related]
11. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
Dhariwala MO; Olson RM; Anderson DM
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
[No Abstract] [Full Text] [Related]
12. A novel autotransporter adhesin is required for efficient colonization during bubonic plague.
Lawrenz MB; Lenz JD; Miller VL
Infect Immun; 2009 Jan; 77(1):317-26. PubMed ID: 18936182
[TBL] [Abstract][Full Text] [Related]
13. Characterization of
Dudte SC; Hinnebusch BJ; Shannon JG
Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
[No Abstract] [Full Text] [Related]
14. Yersinia pestis and the plague.
Rollins SE; Rollins SM; Ryan ET
Am J Clin Pathol; 2003 Jun; 119 Suppl():S78-85. PubMed ID: 12951845
[TBL] [Abstract][Full Text] [Related]
15. Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague.
Reboul A; Lemaître N; Titecat M; Merchez M; Deloison G; Ricard I; Pradel E; Marceau M; Sebbane F
J Infect Dis; 2014 Nov; 210(9):1367-75. PubMed ID: 24813471
[TBL] [Abstract][Full Text] [Related]
16. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
[TBL] [Abstract][Full Text] [Related]
17. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.
Demeure CE; Dussurget O; Mas Fiol G; Le Guern AS; Savin C; Pizarro-Cerdá J
Genes Immun; 2019 May; 20(5):357-370. PubMed ID: 30940874
[TBL] [Abstract][Full Text] [Related]
18. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
[TBL] [Abstract][Full Text] [Related]
19. Role of immune response in Yersinia pestis infection.
Amedei A; Niccolai E; Marino L; D'Elios MM
J Infect Dev Ctries; 2011 Sep; 5(9):628-39. PubMed ID: 21918303
[TBL] [Abstract][Full Text] [Related]
20. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague.
Sebbane F; Jarrett CO; Gardner D; Long D; Hinnebusch BJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5526-30. PubMed ID: 16567636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
